Clinical trial
A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic…
NCT00249860 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00249860 |
|---|---|
| Title | A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects |
| Official title | A Multicentre Phase III Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects |
| Lead sponsor | EMD Serono, Industry |
| Collaborators | Merck Pte. Ltd., Singapore Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | Interferon-beta-1a, Placebo, Ribavirin plus Interferon-beta-1a |
| Enrollment | 257 |
| Start date | Sep 1, 2002 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Nov 7, 2005 |
| Last update posted | Aug 6, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: